Skip to main content
Premium Trial:

Request an Annual Quote

Michigan Proteome Consortium Gets $11.9M NIH Grant

NEW YORK, Oct. 30 - The Michigan Proteome Consortium has received an $11.9-million, five-year grant from the NIH's National Center for Research Resources to further develop its proteomics technologies, according to an Oct. 28. press statement from the NCCR.

 

The consortium, which is led by Philip Andrews, a professor of biological chemistry at the University of Michigan Medical School, has to date received $28 million in funding from the NIH, the University, and other sources.  The Michigan Life Sciences Corridor, a non-profit organization to promote life sciences in the state, provided the consortium with a $13.7 million start-up grant in 2001.

 

"This additional funding from the National Center for Research Resources will make it possible for the Consortium to expand its R&D program in emerging proteomics technologies," Andrews said in a statement. "For proteomics to reach its full potential, we need to develop more sensitive techniques for use with smaller tissue specimens, new mapping technologies, and improved software and computational tools."

 

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.